NEW YORK, June 5-Despite reports that Motorola is planning to leave the biochip business behind, its Life Sciences division announced today that it plans to distribute BioDiscovery's ImaGene software package as part of its CodeLInk bioarray system.
According to the company, BioDiscovery's software platform will allow for the identification of low-signal genes, and allow users to transition to new Motorola microarrays as they are released.
Specific terms of the agreement were not disclosed.
BioDiscovery is a privately held microarray software company based in Marina del Ray, Calif.
Recently, Crain's Chicago Business reported that Motorola was planning to ditch its microarray venturein an effort to cut costs.